Efficacy and Safety of Minocycline in Patients With Moderate to Severe Acute Ischemic Stroke

PHASE3CompletedINTERVENTIONAL
Enrollment

1,724

Participants

Timeline

Start Date

May 19, 2023

Primary Completion Date

May 20, 2024

Study Completion Date

August 15, 2024

Conditions
Ischemic Stroke, Acute
Interventions
DRUG

Minocycline hydrochloride capsule

50 mg per capsule, containing 50mg of Minocycline Hydrochloride.

DRUG

Placebo capsules of Minocycline hydrochloride capsules

50 mg per capsule, containing 0mg of Minocycline Hydrochloride.

Trial Locations (58)

100000

The Eighth Medical Center of PLA General Hospital, Beijing

101300

Beijing Shunyi Hospital, Beijing

117000

Benxi Central Hospital, Benxi

121000

The First Affiliated Hospital of Jinzhou Medical University, Jinzhou

130000

China-Japan Union Hospital of Jilin University, Changchun

Tianjin Xiqing Hospital, Tianjin

200135

Shanghai Pudong New Area Gongli Hospital, Shanghai

213100

Changzhou Wujin Traditional Chinese Medicine Hospital, Changzhou

215000

The Fourth Affiliated Hospital of Soochow University, Suzhou

221000

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

226400

Rudong People's Hospital, Nantong

252000

Liaocheng Central Hospital, Liaocheng

The Third People's Hospital of Liaocheng, Liaocheng

252500

Guanxian People's Hospital, Liaocheng

253400

Ningjin People's Hospital, Dezhou

255000

Zibo Central Hospital, Zibo

256200

Zouping City People's Hospital, Jining

264400

Weihai Wendeng District People's Hospital, Weihai

266000

The Affiliated Hospital of Qingdao University, Qingdao

272000

Affiliated Hospital of Jining Medical University, Jining

300000

Tianjin Huanhu Hospital, Tianjin

310000

Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou

325000

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

332000

Jiujiang University Affiliated Hospital, Jiujiang

400032

Chongqing Donghua Hospital, Chongqing

404000

Chongqing University Three Gorges Hospital, Chongqing

410000

Xiangya Hospital, Central South University, Changsha

415300

Shimen People's Hospital, Changde

421002

Hengyang Central Hospital, Hengyang

423000

The First People's Hospital of Chenzhou/The First Affiliated Hospital of Xiangnan University, Chenzhou

430000

Wuhan No.1 Hospital, Wuhan

450100

Xingyang People's Hospital, Zhengzhou

454350

Xiuwu People's Hospital, Jiaozuo

454750

Mengzhou People's Hospital, Mengzhou

457400

Nanle Zhongxing Hospital, Puyang

459000

Jiyuan Chinese Medical Hospital, Jiyuan

463000

Biyang People's Hospital, Zhumadian

463400

Pingyu People's Hospital, Zhumadian

471000

Luoyang Central Hospital, Luoyang

471100

Mengjin People's Hospital, Luoyang

471700

Luoning People's Hospital, Luoyang

474100

Dengzhou People's Hospital, Dengzhou

476900

Sui Chinese Medical Hospital, Shangqiu

518000

Shenzhen Hospital, Southern Medical University, Shenzhen

Shenzhen Second People's Hospital, Shenzhen

530031

The Second Nanning People's Hospital, Nanning

610000

West China Hospital, Sichuan University, Chengdu

710000

Xi'an International Medical Center Hospital, Xi'an

750000

General Hospital of Ningxia Medical University, Yinchuan

830002

Xinjiang Production&Construction Corps Hospital, Ürümqi

839000

Xinjiang Production and Construction Corps 13 Division Red Star Hospital, Hami

053000

The Sixth People's Hospital of Hengshui, Hengshui

063000

North China University of Science and Technology Affiliated Hospital, Tangshan

014030

Baotou Central Hospital, Baotou

030600

Yuci District People's Hospital, Jinzhong

041000

Linfen Central Hospital, Linfen

030001

First Hospital of Shanxi Medical University, Taiyuan

Unknown

Beijing Tiantan Hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

Neurodawn Pharmaceutical Co., Ltd.

INDUSTRY

lead

Beijing Tiantan Hospital

OTHER